Eastgate Biotech Corp. (OTCMKTS:ETBI – Get Free Report)’s share price crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.00 and traded as high as $0.0003. Eastgate Biotech shares last traded at $0.0003, with a volume of 10,000 shares.
Eastgate Biotech Stock Performance
About Eastgate Biotech
Eastgate Biotech, Inc is a developmental-stage biotechnology company focused on the research and development of advanced lipid nanoparticle (LNP) drug delivery systems. The company’s proprietary platform is designed to facilitate the targeted transport of nucleic acid therapies, including mRNA and siRNA, to specific tissues in order to maximize therapeutic efficacy and minimize off-target effects. By harnessing the versatility of its LNP technology, Eastgate Biotech aims to enable the next generation of precision medicines for a variety of genetic and degenerative conditions.
Leveraging its LNP platform, Eastgate Biotech is assembling a pipeline of preclinical therapeutic candidates, with particular emphasis on ocular and neuromuscular applications.
Further Reading
- Five stocks we like better than Eastgate Biotech
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for Eastgate Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastgate Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
